Today News Journal
    What's Hot

    The Chief Justice’s Wife Has Every Right to Her Legal Career

    February 2, 2023

    Biden Faces His Nixon Moment on Alaskan Oil

    February 2, 2023

    Hindenburg Gives a Masterclass. Adani Flunks

    February 2, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram
    Today News Journal
    Contact Us
    • Home
    • Trending
    • Business
    • Health
    • Technology
      • Automobile
      • Gadgets
      • Mobiles
      • Robotics
    • Lifestyle
      • Culture
    • Sports
    • Travel
    • Editorials
    • News
      • Politics
    Today News Journal
    Home » Health » Alzheimer’s Disease Fast Facts | CNN
    Health

    Alzheimer’s Disease Fast Facts | CNN

    James MartinBy James MartinApril 13, 2022No Comments6 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email




    CNN
     — 

    Here is a look at Alzheimer’s disease, a progressive brain disorder that leads to loss of memory and other intellectual abilities.

    Alzheimer’s disease is the most common form of dementia, which is a general term for the loss of memory and intellectual abilities.

    Alzheimer’s disease is fatal and there is no cure. It is a slow-moving disease that starts with memory loss and ends with severe brain damage.

    The disease is named after Dr. Alois Alzheimer. In 1906, the neuropathologist did an autopsy on the brain of a woman who died after exhibiting language problems, unpredictable behavior and memory loss. Dr. Alzheimer discovered the amyloid plaques and neurofibrillary tangles, which are considered the hallmarks of the disease.

    Contributing Factors:
    Age – The likelihood of developing Alzheimer’s doubles every five years after the age of 65. For most people, symptoms first appear after the age of 60.

    Family history – Genetics play a role in an individual’s risk of developing the disease.

    Head trauma – There is a possible link between the disease and repeated trauma or loss of consciousness.

    Heart health – The risk of vascular dementia increases with heart conditions such as high blood pressure, high cholesterol and diabetes.

    Possible Symptoms:
    Memory loss
    Repeating questions and statements
    Poor judgment
    Misplacing items
    Mood and personality changes
    Confusion
    Delusions and paranoia
    Impulsiveness
    Seizures
    Difficulty swallowing

    According to the CDC, an estimated 6 million Americans have Alzheimer’s disease. It is the fifth leading cause of death for adults in the United States aged 65 or older.

    The estimated cost of caring for patients with Alzheimer’s or other dementias in the United States in 2021 is $355 billion.

    Early-onset Alzheimer’s is an uncommon form of dementia that strikes people younger than age 65.

    Early-onset Alzheimer’s disease often runs in families.

    March 9, 2014 – In a first-of-its-kind study, researchers report they have developed a blood test that predicts with astonishing accuracy whether a healthy person will develop Alzheimer’s disease.

    September 2014 – The research journal Aging reports that in a small study at UCLA, nine out of the 10 patients involved, said their symptoms reversed after they participated in a rigorous program that included things like optimizing Vitamin D levels in the blood, using DHA supplements to bridge broken connections in the brain and strategic fasting to normalize insulin levels.

    September 11, 2015 – The Journal of Neurology publishes a study that suggests that the compound resveratrol, when taken in concentrated doses, may have benefit in slowing the progression of Alzheimer’s disease.

    November 23, 2016 – US drugmaker Eli Lilly announces it is ending the Phase 3 clinical trial of its Alzheimer’s drug solanezumab. “Patients treated with solanezumab did not experience a statistically significant slowing in cognitive decline compared to patients treated with placebo,” the company says in a statement.

    February 2017 – The drug company Merck halts the late-stage trial of its Alzheimer’s drug verubecestat, after an independent study found that it had “virtually no chance” of working.

    July 25, 2018 – Additional results of an early clinical trial for an experimental drug, the antibody called BAN2401, shows that it improved cognition and reduced clinical signs of Alzheimer’s in the brains of study participants. Details about the immunotherapy were announced at a news conference during the 2018 Alzheimer’s Association International Conference.

    February 28, 2019 – The journal Nature Genetics publishes a study that reveals four new genetic variants that increase risk for Alzheimer’s disease. The genes appear to work in tandem to control bodily functions that affect disease development.

    March 21, 2019 – Pharmaceutical company Biogen announces that they are ending two Phase 3 clinical trials of a drug that targets the buildup in the brain of beta-amyloid, one of two proteins that researchers believe contribute to the development of Alzheimer’s. The drug, called aducanumab, was considered to be a promising candidate in improving cognitive function.

    October 22, 2019 – Biogen announces that it will apply for regulatory approval for aducanumab and begin new studies. “The decision to file is based on a new analysis, conducted by Biogen in consultation with the FDA, of a larger dataset from the Phase 3 clinical studies that were discontinued in March 2019 following a futility analysis.”

    March 13, 2021 – The New England Journal of Medicine publishes a study indicating that Eli Lilly and Company’s experimental intravenous drug donanemab could slow the cognitive decline of patients with Alzheimer’s disease, according to early clinical trial results.

    June 7, 2021 – The FDA approves the use of the experimental drug aducanumab for early phases of Alzheimer’s disease, despite an FDA advisory committee concluding last year that there is not enough evidence to support the effectiveness of the treatment. This is the first time since 2003 the FDA has approved a novel therapy for Alzheimer’s.

    April 4, 2022 – A study that uncovered an additional 42 genes connected to the development of Alzheimer’s disease is published.

    April 7, 2022 – The Centers for Medicare and Medicaid Services announces it will restrict coverage of the controversial and costly Alzheimer’s drug Aduhelm to those enrolled in qualifying clinical trials.

    Cathy Greenblat's images of people around the world living with Alzheimer's disease include this unidentified patient with Alzheimer's in Texas who was near the end of her life.

    ‘Seeing Alzheimer’s Differently’ —

    Cathy Greenblat’s images of people around the world living with Alzheimer’s disease include this unidentified patient with Alzheimer’s in Texas who was near the end of her life.

    Before she passed away, Livia enjoyed daily hair salon visits while in hospice for Alzheimer's at a U.S. hospital.

    ‘Seeing Alzheimer’s Differently’ —

    Before she passed away, Livia enjoyed daily hair salon visits while in hospice for Alzheimer’s at a U.S. hospital.

    In the Dominican Republic, Maria's increasing struggle with Alzheimer's forced her to move from her longtime home to a residence in another area where her family could care for her.

    ‘Seeing Alzheimer’s Differently’ —

    In the Dominican Republic, Maria’s increasing struggle with Alzheimer’s forced her to move from her longtime home to a residence in another area where her family could care for her.

    In France, caregiver Bénédicte Cossève works with Mercel in a stimulating and soothing environment. Marcel's rocking chair helps him to concentrate.

    ‘Seeing Alzheimer’s Differently’ —

    In France, caregiver Bénédicte Cossève works with Mercel in a stimulating and soothing environment. Marcel’s rocking chair helps him to concentrate.

    In Japan, this unidentified woman with Alzheimer's enjoyed therapy through music. Joining a drum circle, she became caught up in an intense rhythmic response.

    ‘Seeing Alzheimer’s Differently’ —

    In Japan, this unidentified woman with Alzheimer’s enjoyed therapy through music. Joining a drum circle, she became caught up in an intense rhythmic response.

    Also in Japan, an aide in a Kyoto group home embraced this unidentified resident living with Alzheimer's.

    ‘Seeing Alzheimer’s Differently’ —

    Also in Japan, an aide in a Kyoto group home embraced this unidentified resident living with Alzheimer’s.

    Janette, an ex-attorney, enjoyed playing xylophone while at hospice in the United States during the final days of her life.

    ‘Seeing Alzheimer’s Differently’ —

    Janette, an ex-attorney, enjoyed playing xylophone while at hospice in the United States during the final days of her life.

    In India, Didi arrived at this day care center depressed and using a wheelchair. Now she's more cheerful and walks with little assistance. Didi enjoys a moment with caregiver Ashwani.

    ‘Seeing Alzheimer’s Differently’ —

    In India, Didi arrived at this day care center depressed and using a wheelchair. Now she’s more cheerful and walks with little assistance. Didi enjoys a moment with caregiver Ashwani.

    Jacqueline, a French Alzheimer's patient, needs help getting into bed. Caregiver Cossève wraps her in a soft blanket. <a href=Greenblat’s images were on display at New York’s Pace University.” class=”gallery-image__dam-img”/>

    alzheimers 01 —

    Jacqueline, a French Alzheimer’s patient, needs help getting into bed. Caregiver Cossève wraps her in a soft blanket. Greenblat’s images were on display at New York’s Pace University.



    Source link

    Related posts:

    1. Oxygen stocks running dangerously low in Ukraine
    2. Coffee could benefit your heart and help you live longer
    3. BA.2: What we know about the dominant cause of Covid-19 in the US
    4. CDC director announces sweeping review of agency
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleNASA’s James Webb Space Telescope is ready for calibration after chilling out
    Next Article Australia politics live updates: Coalition poised for forestry and infrastructure announcements, Labor to target marginal NSW seats | Australia news
    James Martin
    • Website

    Related Posts

    How to be prepared in case of a shooting without living in fear

    January 26, 2023

    Many women underestimate breast density as a risk factor for breast cancer, study shows

    January 26, 2023

    Pediatricians are giving out free gun locks to approach the gun violence epidemic as a public health crisis

    January 25, 2023

    CDC figuring out ‘logistical and legal’ aspects of testing airplane wastewater for coronavirus variants, source says

    January 25, 2023

    Leave A Reply Cancel Reply

    Search
    Categories
    • Automobile
    • Business
    • Coronavirus
    • Culture
    • Editorials
    • Finance
    • Gadgets
    • Health
    • Lifestyle
    • Mobiles
    • Money
    • News
    • Politics
    • Sports
    • Technology
    • Travel
    • Trending
    • World
    Latest Posts

    The Chief Justice’s Wife Has Every Right to Her Legal Career

    February 2, 2023

    Biden Faces His Nixon Moment on Alaskan Oil

    February 2, 2023

    Hindenburg Gives a Masterclass. Adani Flunks

    February 2, 2023

    Fed Pivot Is Dead. Long Live the Fed Pirouette.

    February 2, 2023
    • Facebook
    • Twitter
    Don't Miss
    News

    The Chief Justice’s Wife Has Every Right to Her Legal Career

    By James MartinFebruary 2, 20230

    Comment on this storyCommentThe search for conflicts of interest in the personal lives of the…

    Biden Faces His Nixon Moment on Alaskan Oil

    February 2, 2023

    Hindenburg Gives a Masterclass. Adani Flunks

    February 2, 2023

    Fed Pivot Is Dead. Long Live the Fed Pirouette.

    February 2, 2023
    • Facebook
    • Twitter
    About Us

    Hello friends, I am James Martin. Welcome to my blog todaynewsjournal.com. We are a team of experienced journalists who are passionate about delivering the latest news and current events to our readers. Our editorial team is dedicated to providing the most accurate and up-to-date information possible. We aim to be your go-to source for news and current events. Here on this site, You will get up to date information regarding all important categories like business ideas, health tips,... (Read More)

    Latest News

    The Chief Justice’s Wife Has Every Right to Her Legal Career

    February 2, 2023

    Biden Faces His Nixon Moment on Alaskan Oil

    February 2, 2023

    Hindenburg Gives a Masterclass. Adani Flunks

    February 2, 2023
    SIGN UP NEWSLETTER

    Join The Conversation sign up to receive emails for The Daily special tips general info.

      Facebook Twitter Instagram Pinterest
      • Home
      • Editorials
      • Get In Touch

      Copyright © 2021-2023 · Today News Journal Privacy Policy

      Type above and press Enter to search. Press Esc to cancel.

      We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
      Cookie SettingsAccept All
      Manage consent

      Privacy Overview

      This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
      Necessary
      Always Enabled
      Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
      CookieDurationDescription
      cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
      cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
      cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
      cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
      cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
      viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
      Functional
      Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
      Performance
      Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
      Analytics
      Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
      Advertisement
      Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
      Others
      Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
      SAVE & ACCEPT

      Sign In or Register

      Welcome Back!

      Login to your account below.

      Lost password?